NCT04698252View on ClinicalTrials.gov

Local Therapy for ER/PR-positive Oligometastatic Breast Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2031

Conditions
Breast Cancer
Interventions
RADIATION

Radiotherapy

Radiation therapy for oligometastatic sites

PROCEDURE

Surgery

Surgery for oligometastatic sites

OTHER

Radiofrequency ablation

Radiofrequency ablation for oligometastatic sites

Trial Locations (1)

01246-000

RECRUITING

ICESP, São Paulo

All Listed Sponsors
lead

Instituto do Cancer do Estado de São Paulo

OTHER